美国 · 股市与财经 · MarketWatch

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

来源：MarketWatch · 美国 9 小时前

Genmab shares jumped after the biotechnology company and partner AbbVie said their Epkinly drug helped extend the time patients with a common type of lymphoma lived without the…

在 MarketWatch 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketwatch.com)

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

推荐阅读

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

At Least 50 Iranian Tankers Are Stuck in the Gulf as U.S. Blockade Holds

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug

分享

推荐阅读

I'm the CEO of Zocdoc. Here's how long showers help me manage hectic days.

Euro Area retail sales rise 0.8% Y/Y, below estimates

Battle Between Disney and the F.C.C. Moves to the Courts

OKX Money lets users save, earn 10% yield and spend dollar stablecoins in one app

These are the 10 U.S. cities with the most homes at risk of hurricane damage

At Least 50 Iranian Tankers Are Stuck in the Gulf as U.S. Blockade Holds